Reviva Pharmaceuticals Holdings, Inc. Common Stock
RVPH
RVPH: Reviva Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, respiratory, and metabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, 1) Brilaroxazine (RP5063) which is in clinical development and is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and 2) RP1208.
moreShow RVPH Financials
Recent trades of RVPH by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RVPH's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Methods for treating pulmonary hypertension Oct. 15, 2019
-
Patent Title: Arylpiperazine derivatives and methods of utilizing same May. 22, 2018
-
Patent Title: Methods for treating attention deficit hyperactivity disorder Mar. 06, 2018
-
Patent Title: Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives Jul. 04, 2017
-
Patent Title: Arylpiperazine derivatives and methods of utilizing same Mar. 28, 2017
-
Patent Title: Synthesis, methods of using, and compositions of cycloalkylmethylamines Apr. 05, 2016
-
Patent Title: Cycloalkylmethylamines Mar. 29, 2016
-
Patent Title: Arylpiperazine derivatives and methods of utilizing same Feb. 09, 2016
-
Patent Title: Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives Jan. 19, 2016
-
Patent Title: Methods of using cycloalkylmethylamine derivatives Aug. 04, 2015
-
Patent Title: Arylpiperazine derivatives and methods of utilizing same Mar. 17, 2015
-
Patent Title: Methods of utilizing arylpiperazine derivatives Oct. 14, 2014
-
Patent Title: Synthesis, methods of using, and compositions of cycloalkylmethylamines Mar. 11, 2014
-
Patent Title: Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives Dec. 10, 2013
-
Patent Title: Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors Nov. 12, 2013
-
Patent Title: Compositions, synthesis, and methods of utilizing quinazolinedione derivatives Nov. 05, 2013
-
Patent Title: Methods of utilizing arylpiperazine derivatives Jun. 11, 2013
-
Patent Title: Cycloalkylmethylamines May. 21, 2013
-
Patent Title: Methods of utilizing arylpiperazine derivatives Apr. 30, 2013
-
Patent Title: Methods of using cycloalkylmethylamines Feb. 12, 2013
-
Patent Title: Cycloalkylmethylamines Dec. 25, 2012
-
Patent Title: Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors Aug. 21, 2012
-
Patent Title: Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents Aug. 21, 2012
-
Patent Title: Compositions, synthesis, and methods of using piperazine based antipsychotic agents Jun. 26, 2012
-
Patent Title: Compositions, synthesis, and methods of utilizing arylpiperazine derivatives May. 29, 2012
-
Patent Title: Synthesis, methods of using, and compositions of cycloalkylmethylamines Aug. 02, 2011
Federal grants, loans, and purchases
Followers on RVPH's company Twitter account
Number of mentions of RVPH in WallStreetBets Daily Discussion
Recent insights relating to RVPH
Recent picks made for RVPH stock on CNBC
ETFs with the largest estimated holdings in RVPH
Flights by private jets registered to RVPH